<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher>American Diabetes Association</publisher>
				<availability status="unknown"><p>Copyright American Diabetes Association</p>
				</availability>
				<date type="published" when="2008-07-15">2008-07-15</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mingzhan</forename><surname>Xue</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Clinical Sciences Research Institute</orgName>
								<orgName type="department" key="dep2">Warwick Medical School</orgName>
								<orgName type="institution" key="instit1">University of Warwick</orgName>
								<orgName type="institution" key="instit2">University Hospital</orgName>
								<address>
									<settlement>Coventry</settlement>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qingwen</forename><surname>Qian</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">De-partment of Biological Sciences</orgName>
								<orgName type="department" key="dep2">Central Campus</orgName>
								<orgName type="institution">University of Essex</orgName>
								<address>
									<addrLine>Wivenhoe Park</addrLine>
									<settlement>Colchester</settlement>
									<region>Essex, U.K</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonysunil</forename><surname>Adaikalakoteswari</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Clinical Sciences Research Institute</orgName>
								<orgName type="department" key="dep2">Warwick Medical School</orgName>
								<orgName type="institution" key="instit1">University of Warwick</orgName>
								<orgName type="institution" key="instit2">University Hospital</orgName>
								<address>
									<settlement>Coventry</settlement>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naila</forename><surname>Rabbani</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Clinical Sciences Research Institute</orgName>
								<orgName type="department" key="dep2">Warwick Medical School</orgName>
								<orgName type="institution" key="instit1">University of Warwick</orgName>
								<orgName type="institution" key="instit2">University Hospital</orgName>
								<address>
									<settlement>Coventry</settlement>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">De-partment of Biological Sciences</orgName>
								<orgName type="department" key="dep2">Central Campus</orgName>
								<orgName type="institution">University of Essex</orgName>
								<address>
									<addrLine>Wivenhoe Park</addrLine>
									<settlement>Colchester</settlement>
									<region>Essex, U.K</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roya</forename><surname>Babaei-Jadidi</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">De-partment of Biological Sciences</orgName>
								<orgName type="department" key="dep2">Central Campus</orgName>
								<orgName type="institution">University of Essex</orgName>
								<address>
									<addrLine>Wivenhoe Park</addrLine>
									<settlement>Colchester</settlement>
									<region>Essex, U.K</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
							<email>p.j.thornalley@warwick.ac.uk.</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Clinical Sciences Research Institute</orgName>
								<orgName type="department" key="dep2">Warwick Medical School</orgName>
								<orgName type="institution" key="instit1">University of Warwick</orgName>
								<orgName type="institution" key="instit2">University Hospital</orgName>
								<address>
									<settlement>Coventry</settlement>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">De-partment of Biological Sciences</orgName>
								<orgName type="department" key="dep2">Central Campus</orgName>
								<orgName type="institution">University of Essex</orgName>
								<address>
									<addrLine>Wivenhoe Park</addrLine>
									<settlement>Colchester</settlement>
									<region>Essex, U.K</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Diabetes</title>
						<title level="j" type="abbrev">Diabetes</title>
						<idno type="ISSN">0012-1797</idno>
						<idno type="eISSN">1939-327X</idno>
						<imprint>
							<publisher>American Diabetes Association</publisher>
							<biblScope unit="volume">57</biblScope>
							<biblScope unit="issue">10</biblScope>
							<biblScope unit="page" from="2809" to="2817"/>
							<date type="published" when="2008-07-15" />
						</imprint>
					</monogr>
					<idno type="DOI">10.2337/db06-1003</idno>
					<idno type="PMID">18633117</idno>
					<idno type="PMCID">PMC2551693</idno>
					<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/57/10/2809.full.pdf" />
					<note type="submission">Received 19 July 2006 and accepted 1 July 2008.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:58+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>OBJECTIVE-Sulforaphane is an activator of transcription factor NF-E2-related factor-2 (nrf2) that regulates gene expression through the promoter antioxidant response element (ARE). Nrf2 regulates the transcription of a battery of protective and metabolic enzymes. The aim of this study was to assess whether activation of nrf2 by sulforaphane in human microvascular endothelial cells prevents metabolic dysfunction in hyperglycemia. RESEARCH DESIGN AND METHODS-Human microvascular HMEC-1 endothelial cells were incubated in low and high glucose concentrations (5 and 30 mmol/l, respectively), and activation of nrf2 was assessed by nuclear translocation. The effects of sulforaphane on multiple pathways of biochemical dysfunction, increased reactive oxygen species (ROS) formation, hexosamine pathway, protein kinase C (PKC) pathway, and increased formation of methylglyoxal were assessed. RESULTS-Activation of nrf2 by sulforaphane induced nuclear translocation of nrf2 and increased ARE-linked gene expression, for example, three-to fivefold increased expression of transketolase and glutathione reductase. Hyperglycemia increased the formation of ROS-an effect linked to mitochondrial dysfunction and prevented by sulforaphane. ROS formation was increased further by knockdown of nrf2 and transketolase expression. This also abolished the counteracting effect of sulforaphane, suggesting mediation by nrf2 and related increase of transketolase expression. Sulforaphane also prevented hyperglycemia-induced activation of the hexosamine and PKC pathways and prevented increased cellular accumulation and excretion of the glycating agent methylglyoxal. CONCLUSIONS-We conclude that activation of nrf2 may prevent biochemical dysfunction and related functional responses of endothelial cells induced by hyperglycemia in which increased expression of transketolase has a pivotal role.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T</head><p>here is an increased risk of vascular disease in diabetes that is a major cause of patient morbidity and mortality. This gives rise to a characteristic spectrum of diabetic microvascular disease (retinopathy, nephropathy, and neuropathy) and macrovascular disease (heart disease and stroke) <ref type="bibr" target="#b0">(1)</ref><ref type="bibr" target="#b1">(2)</ref><ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref>. Vascu-lar disease in diabetes is associated with dysfunction of endothelial cells in hyperglycemia. Activation of multiple pathways of biochemical dysfunction induced in vascular endothelial cells by high glucose concentration is thought to underlie the link of hyperglycemia in diabetes to the development of vascular disease <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6)</ref>. A common feature of endothelial cell dysfunction in hyperglycemia is increased formation of reactive oxygen species (ROS) by mitochondria, oxidative stress with inactivation of glyceraldehyde-3-phosphate dehydrogenase, and accumulation of triosephosphates and fructose-6-phosphate <ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref>. There is an associated activation of protein kinase C (PKC), hexosamine pathway O-linked protein glycosylation, and increased glycation by methylglyoxal and other dicarbonyls forming advanced glycation end products <ref type="bibr">(10 -12)</ref>. This appears to be driven mainly by the accumulation of glycolytic intermediates. Recent research has indicated that activation of the reduced pentosephosphate pathway by high-dose thiamine and related prodrug benfotiamine may counter this metabolic dysfunction <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14)</ref>, but little is known of the endogenous coordinated stress response to decrease triosephosphate accumulation and its link to increased ROS formation and oxidative stress in hyperglycemia.</p><p>NF-E2-related factor-2 (nrf2) is a member of the cap 'n' collar subfamily of bZIP transcription factors. It is an essential transactivator of genes containing an antioxidant response element (ARE) in their promoter (rev. in <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16)</ref>. ARE-linked genes include a battery of protective and metabolic enzymes: ␥-glutamylcysteine ligase, glutathione reductase (GSHRd), aldo-keto reductase (AKRd), glutathione transferases, quinone reductase (NQO1), nrf2 <ref type="bibr" target="#b16">(17)</ref>, and others <ref type="bibr" target="#b17">(18)</ref>. Nrf2-linked gene expression has a key role in the protection of cells against oxidative stress, carbonyl compounds, and electrophilic agents. Interestingly, the thiamine-dependent enzyme transketolase and transaldolase are also ARE-linked genes <ref type="bibr" target="#b17">(18)</ref>. Transketolase is considered to be the rate-controlling enzyme in the pentosephosphate pathway.</p><p>Under basal conditions, nrf2 is complexed with Kelchlike ECH-associated protein 1 (Keap1), a BTB-Kelch protein. Keap1 is a substrate adaptor protein for a Cul 3-dependent E3 ubiquitin ligase complex, directing nrf2 for proteasomal degradation <ref type="bibr" target="#b18">(19)</ref>. Oxidative stress, electrophiles, and sulforaphane-like inducers disrupt the Keap1-nrf2 complex: nrf2 translocates to the nucleus and, combining with small maf protein <ref type="bibr" target="#b19">(20)</ref>, induces ARElinked gene expression <ref type="bibr" target="#b20">(21)</ref>. Sulforaphane releases nrf2 from Keap1 by modification of critical cysteine thiol residues <ref type="bibr" target="#b21">(22)</ref>. Keap1 has concurrent increased susceptibility to degradation but also has ARE-linked gene expression and may be induced by nrf2 activation, providing an autoregulatory feedback loop <ref type="bibr" target="#b22">(23)</ref>. Nrf2 also undergoes nuclear export, establishing cytoplasmic/nuclear dynamic shuttling <ref type="bibr" target="#b23">(24)</ref>. Recent research has suggested that the serine/threonine kinase CK2 has a role in nuclear import of nrf2 and that both CK2 and tyrosine kinase Fyn influence nuclear export and degradation of nrf2 <ref type="bibr" target="#b24">(25,</ref><ref type="bibr" target="#b25">26)</ref>  <ref type="figure">(Fig. 1A</ref>).</p><p>There is an active nrf2-Keap-1 system in vascular endothelial cells <ref type="bibr" target="#b26">(27)</ref>.</p><p>The role, if any, of nrf2-linked gene expression in countering endothelial dysfunction in hyperglycemia has not been disclosed. Disposal of glyceraldehyde-3-phosphate and fructose-6-phosphate by the reductive pentose- </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>. Nrf2 activation and transketolase expression in human HMEC-1 endothelial cells in vitro. A: Schematic diagram showing activation of nrf2 and dynamic nuclear-cytoplasmic shuttling of nrf2 for ARE-linked expression. B: Multiple pathways of biochemical dysfunction induced by hyperglycemia in microvascular endothelial cells and effect of nrf2 activated, ARE-mediated induction of transketolase expression. Other mechanisms of biochemical dysfunction may be involved.</head><p>phosphate pathway induced by activation of nrf2 and increased expression of transketolase suggested a possible mechanism of intervention. In this report, we show that activation of nrf2 by the dietary activator sulforaphane, limited to concentration ranges found in plasma after consumption of broccoli <ref type="bibr" target="#b27">(28)</ref> for relevance to future clinical dietary intervention, increased the expression of protective enzymes under ARE-linked transcriptional control and prevented metabolic dysfunction in endothelial cells induced by hyperglycemia in which increased expression of transketolase has a critical role.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESEARCH DESIGN AND METHODS</head><p>Reagents. MCDB-131 medium, FCS, Alexa Fluor 488 rabbit anti-mouse IgG and 2Ј,7Ј-dichlorodihydrofluorescein diacetate (H 2 DCFDA) were purchased from Invitrogen (Paisley, U.K.). Monoclonal (mouse) anti-O-linked N-acetylglucosamine (Clone RL2) was purchased from Abcam (Cambridge, U.K.). All other chemicals were obtained from Sigma-Aldrich (Poole, Dorset, U.K.), unless otherwise stated. Cell culture. Human microvascular HMEC-1 endothelial cells were cultured as described previously <ref type="bibr" target="#b28">(29)</ref>. HMEC-1 cells (4 -6 ϫ 10 6 ) were incubated in MCDB-131 medium with 10% serum, 10 mmol/l L-glutamine, 10 ng/ml epidermal growth factor, and 1 g/ml hydrocortisone in 92-mm-diameter Petri dishes with low glucose (5 mmol/l) and high glucose (30 mmol/l) in the absence and presence of 4 mol/l sulforaphane for 6 -48 h, trypsinized, and analyzed as described below. Small interfering RNA transfection. HMEC-1 endothelial cells were incubated in MCDB-131 medium with 10% serum and then transfected with small interfering RNA (siRNA) for nrf2 (SI00657030; Qiagen) or transketolase (SI02653791) using the HiPerfect transfection reagent according to the manufacturer's instructions. The incubation was then continued with normal medium for 24 h. Cultures were then continued with low and high glucose concentrations in the absence and presence of 4 mol/l sulforaphane for 6 or 24 h and/or other additives. Knockdown was confirmed by real-time RT-PCR for nrf2 and transketolase. RNA was extracted using the RNeasy minikit (Qiagen), reverse transcribed by SuperScript III First Strand Synthesis system (Invitrogen), and quantified by real-time RT-PCR using the TaqMan MGB probes, designed and supplied by Applied Biosystems. Knockdown was 60% for transketolase and Ͼ90% for nrf2. Nuclear translocation of nrf2 by immunoblotting. Nuclear and cytosolic proteins were isolated from HMEC-1 cells incubated with and without sulforaphane using a CelLytic NuCLEAR extraction kit (Sigma). Trypsinized cells were washed in PBS at 4°C, and the cell pellet was lysed with hypotonic lysate buffer containing dithiothreitol, a protease inhibitor cocktail, and IGEPAL CA-630 on ice for 15 min. The lysate was centrifuged (11,000 ϫ g, 30 s, 4°C), and the supernatant was used for the cytosolic extract. The pellet (crude nuclear fraction) was treated with extraction buffer containing dithiothreitol and protease inhibitor cocktail at 4°C for 30 min, vortex mixed, and centrifuged (21,000 ϫ g, 4°C, 5 min). The supernatant was collected for the nuclear extract. All protein extracts were frozen at Ϫ80°C immediately until further analysis. The protein concentration was determined with EZQ Protein Quantitation kit (Invitrogen).</p><p>Proteins in the cytosolic and nuclear fractions were separated by 10% SDS-PAGE and transferred electrophoretically onto polyvinylidene difluoride membrane, and the membrane was blocked with 5% nonfat milk in Trisbuffered saline-Tween buffer (10 mmol/l Tris-HCl, pH 7.5; 150 mmol/l NaCl; and 0.05% Tween-20). The membrane was probed with anti-nrf2 antibody (H-300; 1:1,500 dilution) overnight at 4°C. After washing, the membrane was incubated with horseradish peroxidase-conjugated second antibody (1:3,000 diluted; Sigma) for 1 h at room temperature, and immunoconjugate was detected with enhanced chemiluminescence. The membrane was then incubated with stripping buffer (100 mmol/l ␤-mercaptoethanol, 2% SDS, and 62.5 mmol/l Tris-HCl, pH 6.8), blocked with 5% nonfat milk in Tris-buffered saline-Tween buffer, and reprobed with antibodies to reference proteins ␤-actin and lamin A. Protein band intensities were quantified using Image-Quant TL software (Amersham Biosciences). Characterization of biochemical dysfunction. The intracellular formation of ROS was detected using the fluorogenic probe H 2 DCFDA. Cells (2 ϫ 10 6 ) were incubated with and without sulforaphane and mitochondrial inhibitors for 24 h, washed with PBS, and then incubated further with 20 mol/l H 2 DCFDA for 45 min, washed again, and analyzed by flow cytometry. Shorter incubations of 1-h preincubation in hyperglycemia with and without mitochondrial inhibitors were also performed by microplate fluorescence mea-surements, normalizing the fluorescence intensity to cell number. The effect of treatments on cell viability was assessed by Trypan blue exclusion.</p><p>Hexosamine pathway activity was assessed by a quantitative dot Western blot assay for O-linked N-acetylglucosamine modified protein. Cytosolic protein extracts (0.7 g in 5 l PBS) were immunoblotted with RL2 antibody (1:800 dilution in blocking buffer) for 3 h at room temperature, blocked with 10% BSA, and washed <ref type="bibr" target="#b29">(30)</ref>. The immunocomplexes were detected with Alexa Fluor 488 rabbit anti-mouse IgG (1:700 dilution) and quantified by microplate fluorimetry. The concentrations of methylglyoxal in HMEC-1 cells and medium of cultures with and without sulforaphane were determined by derivatization with 1,2-diaminobenzene and quantitation by liquid chromatography with tandem mass spectrometric detection and stable isotopic dilution analysis <ref type="bibr" target="#b11">(12)</ref>. PKC activity was assayed in membrane and particulate fractions of HMEC-1 cells with exogenous diacylglycerol (1,2-dioleoyl-sn-glycerol; DAG) activator and epidermal growth factor receptor peptide fragment VRKRTLRRL as substrate <ref type="bibr" target="#b8">(9)</ref>. Statistical analyses. All statistical analyses were performed using paired Student's t test, and results are expressed as means Ϯ SD. A P value Ͻ0.05 was considered to be significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Activation of nrf2 and ARE-linked gene expression in endothelial cells by the dietary activator sulforaphane.</head><p>We investigated the activation status of nrf2 in human microvascular endothelial cells by assessing nuclear translocation of human nrf2 by immunoblotting in cytosolic and nuclear fractions and confocal microscopy of nrf2-GFP fusion protein. HMEC-1 endothelial cells incubated in model hyperglycemia (30 mmol/l glucose) showed no significant nuclear translocation of nrf2 with respect to normoglycemic control (5 mmol/l glucose) after incubation for 6 h. Addition of 4 mol/l sulforaphane gave a twofold increase in nuclear nrf2 in both normoglycemic and hyperglycemic cultures. In the normoglycemic culture, the concentration of nrf2 in the cytosol was decreased concomitantly; whereas in the hyperglycemic culture, the concentration of nrf2 in the cytosol was increased. This suggests that the double insult of hyperglycemia and sulforaphane increased the cellular content of nrf2 protein ( <ref type="figure" target="#fig_1">Fig. 2A and B)</ref>. This concentration of sulforaphane did not induce significant cytotoxicity in HMEC-1 cells in incubations for up to 48 h, as assessed in previous studies <ref type="bibr" target="#b30">(31)</ref>. Transketolase activity of HMEC-1 cells was determined spectrophotometrically, as we have previously described <ref type="bibr" target="#b8">(9)</ref>.</p><p>Real-time RT-PCR analysis of target ARE-linked gene expression revealed a marked fivefold induction of transketolase mRNA in cells stimulated with sulforaphane <ref type="figure" target="#fig_2">(Fig. 3A)</ref> and a lower, three-to fourfold increase in GSHRd mRNA <ref type="figure" target="#fig_2">(Fig. 3B)</ref>. The cytosolic activity of transketolase was increased 40 -60% by exposure to sulforaphane <ref type="figure" target="#fig_2">(Fig. 3C)</ref>. The increase in expression of transketolase induced by sulforaphane in normoglycemic and hyperglycemic cultures was prevented by knockdown of nrf2 expression <ref type="figure" target="#fig_2">(Fig. 3A)</ref>. To confirm that there is an ARE-linked induction of gene expression by sulforaphane in HMEC-1 cells, we studied the mRNA levels of the typical nrf2-linked, ARE-mediated gene, NQO1. NQO1 expression, normalized to culture in normoglycemia, was increased approximately twofold in HMEC-1 cells incubated with 4 mol/l sulforaphane in normoglycemic and hyperglycemic conditions. Basal and sulforaphane-induced expression of NQO1 in hyperglycemic culture was decreased 56 and 31%, respectively, by knockdown of nrf2 with siRNA <ref type="figure" target="#fig_2">(Fig. 3D)</ref>. Increased formation of ROS by endothelial cells in hyperglycemia, reversal by sulforaphane, and critical role of transketolase. To examine the effect of ARElinked gene expression on biochemical dysfunction in hyperglycemia, the cellular production of ROS was quantified. Hyperglycemic culture of endothelial cells produced a threefold increased formation of ROS <ref type="figure" target="#fig_3">(Fig. 4A)</ref>. This was not induced by the addition of 25 mmol/l L-glucose (which does not permeate into endothelial cells) to the normoglycemic control. Incubation of endothelial cells with sulforaphane reversed the increase in ROS by 73%, suggesting that activation of ARE-linked gene expression prevented increased ROS formation. Increased ROS formation by HMEC-1 cells in hyperglycemic cultures was prevented by incubation for 60 min with mitochondrial inhibitors (ROS formation [percentage of normoglycemic control]: 10 mol/l p-trifluoromethoxycarbonylcyanide phenylhydrazone, 94 Ϯ 3%; 5 mol/l rotenone, 104 Ϯ 3%; and 2 mol/l myxothiazole, 88 Ϯ 3%). This suggests that dysfunction of mitochondria was a primary source of the increased ROS and electron flux, although complexes I and III contributed to this effect. Incubation of HMEC-1 cells with these inhibitors for 24 h decreased cell viability by 40 -50% and masked the effect of rotenone. We next sought evidence of whether the prevention of increased formation of ROS was dependent on nrf2. We transfected endothelial cells with siRNA to knockdown expression of nrf2 and confirmed this by PCR and real-time RT-PCR ( <ref type="figure" target="#fig_3">Fig. 4B)</ref>. Decreasing the expression of nrf2 exacerbated ROS production in both normoglycemic and hyperglycemic cultures; ROS was increased 145% with 5 mmol/l glucose and 190% with 30 mmol/l glucose, with respect to cells with 5 and 30 mmol/l glucose transfected with scrambled siRNA. The increased formation of ROS with nrf2 knockdown was maintained and not reversed by sulforaphane, which is consistent with the prevention of increased ROS by sulforaphane being mediated by activation of nrf2 rather than a direct antioxidant effect of sulforaphane. Knockdown of transketolase by transfection of endothelial cells with siRNA also exacerbated ROS production in both normoglycemic and hyperglycemic cultures: ROS was increased 247 and 131%, respectively, with respect to cultures with 5 and 30 mmol/l glucose transfected with scrambled siRNA. The increased formation of ROS with transketolase siRNA knockdown was maintained and not reversed by sulforaphane, consistent with the prevention of increased ROS by sulforaphane being mediated by increased expression of transketolase <ref type="figure" target="#fig_3">(Fig. 4B)</ref>. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Multiple pathways of biochemical dysfunction in endothelial cells in hyperglycemia and reversal by sulforaphane. Reversal of increased mitochondrial ROS</head><p>formation is expected to counter biochemical dysfunction in multiple pathways. Hyperglycemia increased the activity of PKC by 180% in the cytosolic fraction and by 347% in the membrane fraction of HMEC-1 endothelial cells. These increases were reversed partially in both cytosolic and membrane fractions by sulforaphane: The hyperglycemiainduced increase in PKC activity was reversed 40% in the cytosolic fraction and 67% in the membrane fraction ( <ref type="figure" target="#fig_4">Fig.  5A and B)</ref>. Similarly, hexosamine pathway-activated enzymatic O-linked glycosylation increased twofold in hyperglycemia and was reversed by sulforaphane ( <ref type="figure" target="#fig_4">Fig. 5C)</ref>. Finally, the concentrations of methylglyoxal in HMEC-1 cells and medium was increased twofold in hyperglycemia and reversed by sulforaphane <ref type="figure" target="#fig_4">(Fig. 5D</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>The reversal of biochemical dysfunction of endothelial cells in hyperglycemia by sulforaphane suggests that acti- export, and degradation, which may be enhanced by ARE-linked expression of Keap1 <ref type="bibr" target="#b22">(23,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b32">33)</ref>. Nrf2 may also exhibit ARE-linked expression. Quantitative Western blotting for nrf2 revealed increased nrf2 in both the nucleus and cytosol in hyperglycemia with sulforaphane treatment, suggesting that total cellular nrf2 protein had increased but only with costimulation from both sulforaphane and hyperglycemia. The expression of nrf2 is ARE-regulated with nrf2 binding to its own promoter <ref type="bibr" target="#b16">(17)</ref>. Hyperglycemia may synergize with sulforaphane to increase nrf2 via ARE-induced expression by increasing endogenous activators of nrf2, such as 4hydroxynonenal (34), increasing the activity of CK2 via Ca 2ϩ /calmodulin-dependent mechanisms <ref type="bibr" target="#b24">(25,</ref><ref type="bibr" target="#b34">35)</ref> or other activatory mechanism. This may reflect an ARElinked, antistress response to hyperglycemia in endothelial cells, albeit too weak to mount an adequate defense against the metabolic insult. Although nrf2 activation leads to increased expression of enzymes linked to antioxidant functions countering oxidative stress, in this study, increased expression of transketolase made a critical and pivotal intervention. The increased reductive pentosephosphate pathway activity thereby achieved counters the accumulation of triosephosphates and fructose-6-phosphate driving metabolic dysfunction <ref type="bibr" target="#b8">(9)</ref>. The protective role of the reductive pentosephosphate pathway in ARE-linked gene expression has hitherto not been identified, although increased transketolase expression is associated with the dietary restriction model of healthy ageing <ref type="bibr" target="#b35">(36)</ref>. Enzymatic activity of transketolase in the pentosephosphate pathway produces indirectly the NADPH cofactor for other ARE-linked gene products, GSHRd, AKRd, NQO1, and thioredoxin reduc-tase, that contribute to countering the effects of oxidative stress <ref type="bibr" target="#b36">(37)</ref>. Therefore, contributions of other ARE-linked gene expression in synergism with transketolase in reversal metabolic dysfunction in hyperglycemia cannot be excluded.</p><p>Multiple pathways of biochemical dysfunction in HMEC-1 cells induced by hyperglycemia were reversed by sulforaphane, except reversal of PKC activation was resistant to the response. This may be due to ARE-linked induced expression of 1-acylglycerol-3-phosphate O-acyltransferase 3 by sulforaphane <ref type="bibr" target="#b37">(38)</ref>. This enzyme converts lysophosphatidic acid to phosphatidic acid, a precursor of the PKC activator DAG in de novo synthesis stimulated in hyperglycemia. The increased expression of this ARElinked gene may maintain increased levels of DAG, although the increased concentrations of glycolytic intermediates upstream driving de novo synthesis of DAG are expected to have been corrected. Prolonged exposure to increased levels of DAG has been suggested as a stimulus of increased PKC expression in hyperglycemia associated with diabetes that may underlie the increased specific activity of PKC in both membrane and cytosolic cell fractions found herein. Alternatively, when we studied activation of transketolase by high-dose thiamine supplements (7), we also found an incomplete reversal of hyperglycemia-induced increase in PKC activity. This may suggest that factors other than those influenced by transketolase contribute to PKC activation in hyperglycemia.</p><p>The prevention of nrf2 activation by sulforaphane by addition of GSH may be interpreted as an effect of GSH acting as an antioxidant. However, sulforaphane and other isothiocyanates bind reversibly to nonprotein thiols, such as GSH, decreasing the concentration of free sulforaphane available to modify Keap1. The residual low concentration of free sulforaphane is inadequate to produce a pharmacological response and undergoes slow inactivation by spontaneous hydrolysis <ref type="bibr" target="#b38">(39)</ref>. The inhibition of nrf2 activation by GSH may, therefore, also reflect interception of sulforaphane in the extracellular medium and prevention of it reaching the cellular receptors, such as Keap1. Sulforaphane and related isothiocyanates are cytotoxic to endothelial cells and other cells at higher concentrations than used herein (typically 20 -40 mol/l) <ref type="bibr" target="#b30">(31,</ref><ref type="bibr" target="#b39">40)</ref>. The cytotoxicity is mediated through interactions with death receptors and apoptotic signaling (41), also involving inhibition of p38 mitogen-activated protein kinase <ref type="bibr" target="#b41">(42)</ref>, mitogen-activated protein kinase kinase kinase-1 <ref type="bibr" target="#b42">(43)</ref>, and protein phosphatase M3/6 (44), and activation of extracellular signal-related kinase 1/2 and Jun NH 2terminal kinase <ref type="bibr" target="#b44">(45)</ref>. This is independent of the disruption of the Keap1-nrf2 complex. Such concentrations of sulforaphane are higher than achieved by Brassica spp. vegetable consumption <ref type="bibr" target="#b27">(28)</ref>, and related cell signaling is expected to be of limited relevance to dietary exposures of sulforaphane.</p><p>There was increased formation of ROS by HMEC-1 cells in model hyperglycemia of 30 mmol/l D-glucose. The lack of similar effect induced by L-glucose indicated that glucose entry and metabolism into cells was required for increased ROS formation. Increased ROS formation was linked to mitochondrial dysfunction, consistent with previous reports <ref type="bibr" target="#b9">(10)</ref>, in which complexes I and III were involved-the former probably by reverse electron flow from complex II <ref type="bibr" target="#b45">(46)</ref>. Incubation of HMEC-1 cells with the mitochondrial inhibitors for 24 h produced significant cytotoxicity and masked the role of complex I in hyperglycemia-induced ROS formation. Incubation with inhibitors for 1 h did not induce cytotoxicity. Similar effects may have compromised the outcome of previous studies of this type <ref type="bibr" target="#b46">(47)</ref>. Other sources of increased ROS formation in microvascular endothelial cells in hyperglycemia have been identified: activation of vascular NADPH oxidase; inactivation and uncoupling of endothelial nitric oxide synthase <ref type="bibr" target="#b47">(48,</ref><ref type="bibr" target="#b48">49)</ref>; and related upstream signaling linked to poly(ADP-ribose) polymerase (PARP) (7), aldose reductase <ref type="bibr" target="#b49">(50)</ref>, and the xanthine/xanthine oxidase system <ref type="bibr" target="#b50">(51)</ref>. Mitochondrial metabolism appears to be a major site of ROS formation in the HMEC-1 cell culture model. There are interrelated mechanisms, however, that may explain how sulforaphane-induced ARE-linked gene expression could prevent activation of other pathways. Activation of PARP may be prevented by sulforaphane-induced increased expression of antioxidant enzymes, preventing oxidative damage to DNA. The activation of the polyol pathway may be prevented by sulforaphane decreasing the cellular concentration of methylglyoxal and thereby preventing methylglyoxal-induced expression of aldose reductase <ref type="bibr" target="#b51">(52)</ref>.</p><p>These findings provide the biochemical basis for the link of a vegetable-rich diet with decreased endothelial dysfunction <ref type="bibr" target="#b52">(53)</ref>, including that part of the Mediterranean diet <ref type="bibr" target="#b53">(54)</ref>, suggesting that dietary exposure to nrf2 activators derived from cruciferous vegetables may have be involved. The functional importance of this finding requires further evaluation. It is expected that the protective effect of nrf2 activators may be stratified by severity of exposure to hyperglycemia, with increasing effects in the nondiabetic, impaired glucose tolerance, and diabetic populations. Hyperglycemia alone did not induce ARE-linked gene expres-sion in HMEC-1 endothelial cells, even when confronted with damaging insults of oxidative stress and accumulation of dicarbonyls. Physiological activators of nrf2 are thought to be the lipid peroxidation-derived aldehyde, 4-hydroxynonenal, and J 3 -isoprostanes <ref type="bibr" target="#b33">(34,</ref><ref type="bibr" target="#b54">55)</ref>. The metabolic insult of hyperglycemia is of nonlipidic origin. This may be why the nrf2 system does not respond strongly to it. There is now evidence that diabetes does induce a weak nrf2-mediated protective response, for example, in the high-fat-diet mouse model of type 2 diabetes <ref type="bibr" target="#b55">(56)</ref>. The weak response suggests that an effective protection to prevent vascular disease has not been mounted and, therefore, provides a clear future opportunity for pharmacological intervention. Cruciferous vegetable consumption and synthetic activators of nrf2 are expected to decrease the risk of vascular disease in diabetes.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>FIG. 1. Nrf2 activation and transketolase expression in human HMEC-1 endothelial cells in vitro. A: Schematic diagram showing activation of nrf2 and dynamic nuclear-cytoplasmic shuttling of nrf2 for ARE-linked expression. B: Multiple pathways of biochemical dysfunction induced by hyperglycemia in microvascular endothelial cells and effect of nrf2 activated, ARE-mediated induction of transketolase expression. Other mechanisms of biochemical dysfunction may be involved.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIG. 2 .</head><label>2</label><figDesc>Nuclear translocation of nrf2 in human HMEC-1 endothelial cells in vitro activated by sulforaphane. Nuclear fraction (A) and cytosolic fraction (B) immunoblotting for nrf2 (98-kDa band). Densitometric intensity ratios are means ؎ SD (n ‫؍‬ 3). N, 5 mmol/l glucose; H, 30 mmol/l glucose; N؉SFN, 5 mmol/l glucose ؉ 4 mol/l sulforaphane; and H؉SFN, 30 mmol/l glucose ؉ 4 mol/l sulforaphane. *P &lt; 0.05, **P &lt; 0.01, and ***P &lt; 0.001 with respect to N; E P &lt; 0.05 and EE P &lt; 0.01 with respect to H.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIG. 3 .</head><label>3</label><figDesc>Effect of sulforaphane on ARE-linked gene expression in HMEC-1 endothelial cells in hyperglycemic culture in vitro. A: Effect of hyperglycemia and sulforaphane on expression of transketolase, with and without knockdown of nrf2. B: Effect of hyperglycemia and sulforaphane on expression of GSHRd. C: Transketolase activity of HMEC-1 cells; effect of hyperglycemia and sulforaphane. D: Effect of hyperglycemia and sulforaphane on expression of NQO1. Transketolase, GSHRd, and NQO1 mRNA were quantified by real-time RT-PCR; AN(nrf2), transfection for nrf2 knockdown. Data are means ؎ SD (n ‫؍‬ 3, except n ‫؍‬ 6 for transketolase activity). *P &lt; 0.05, **P &lt; 0.01, and ***P &lt; 0.001 with respect to N; EE P &lt; 0.01 with respect to H.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG. 4 .</head><label>4</label><figDesc>vation of nrf2 and related ARE-linked gene expression is a novel strategy to suppress endothelial cell dysfunction and possibly also the development of vascular disease in diabetes. For example, decreased cellular and extracellular secretion of methylglyoxal is expected to prevent dicarbonyl glycation of cellular and extracellular matrix proteins and to prevent hyperglycemia-induced endothelial cell detachment and anoikis<ref type="bibr" target="#b11">(12)</ref>. Similarly increased ARE-linked gene expression in human aortal endothelial cells engineered by adenovirus-mediated expression of Nrf2 protected human aortal endothelial cells from cytotoxicity induced by hydrogen peroxide and tumor necrosis factor-␣-induced increased expression of monocyte chemoattractant protein-1 and vascular adhesion molecule-1. This suggests that increased activation of nrf2 may also confer antiatherogenic activity<ref type="bibr" target="#b31">(32)</ref>.Activation of nrf2 by sulforaphane produced nuclear accumulation of the 98-kDa band of nrf2 protein. The 98-kDa band has ARE binding activity and is produced by kinase CK2-catalyzed phosphorylation. Nrf2 levels in cells are regulated by further phosphorylation, nuclearBiochemical dysfunction in HMEC-1 endothelial cells in hyperglycemic culture and reversal by sulforaphane in vitro: ROS formation. A and B: Assessment of cellular ROS formation. H(L؊), 5 mmol/l D(؉)-glucose with 25 mmol/l L(؊)-glucose; AN(nrf2), transfection with siRNA for nrf2 knockdown; AN(TK), transfection with siRNA for transketolase knockdown; and AN(scr), transfection with scrambled sequence siRNA. Data are means ؎ SD (n ‫؍‬ 3). * and E Significance with respect to normoglycemic (N) and hyperglycemic (H) control, respectively, with 1, 2, and 3 symbols representing P &lt; 0.05, 0.01, and 0.001, respectively.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIG. 5 .</head><label>5</label><figDesc>Biochemical dysfunction in HMEC-1 endothelial cells in hyperglycemic culture and reversal by sulforaphane in vitro. A and B: Cytosolic and membrane PKC activity, respectively. C: O-linked protein glycosylation of cell protein extracts. D: Effect on methylglyoxal concentrations: concentration in culture medium (f) and cellular content (Ⅺ). Data are means ؎ SD (n ‫؍‬ 3). *P &lt; 0.05, **P &lt; 0.01, and ***P &lt; 0.001 with respect to N; EE P &lt; 0.01 and EEE P &lt; 0.001 with respect to H.</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">DIABETES, VOL. 57, OCTOBER 2008</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p>This work has received support from the Juvenile Diabetes Research Foundation International (New York), the Wellcome Trust (U.K.), and the Biotechnology and Biosciences Research Council (U.K.).</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cda</forename><forename type="middle">D A</forename><surname>Stehouwer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-A</forename><surname>Gall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jwr</forename><forename type="middle">W R</forename><surname>Twisk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Knudsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Emeis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-H</forename><surname>Parving</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.51.4.1157</idno>
		<idno type="PMID">11916939</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/51/4/1157.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1157" to="1165" />
			<date type="published" when="2002-04-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>De Jager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kooy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Kostense</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Nijpels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Heine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Bouter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cda</forename><surname>Stehouwer</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.atv.0000215951.36219.a4</idno>
		<idno type="PMID">16514084</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.0000215951.36219.a4" />
	</analytic>
	<monogr>
		<title level="j">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<title level="j" type="abbrev">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<idno type="ISSN">1079-5642</idno>
		<idno type="ISSNe">1524-4636</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1086" to="1093" />
			<date type="published" when="2006-02-09" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The relationship between glucose and incident cardiovascular events</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Coutinho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Gerstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="233" to="240" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes: The Framingham Offspring Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Meigs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>O'donnell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">H</forename><surname>Tofler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Lipinska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>D'agostino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">W F</forename><surname>Wilson</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.55.02.06.db05-1041</idno>
		<idno type="PMID">16443791</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/55/2/530.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="530" to="537" />
			<date type="published" when="2006-01-27" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Biochemistry and molecular cell biology of diabetic complications</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Brownlee</surname></persName>
		</author>
		<idno type="DOI">10.1038/414813a</idno>
		<idno type="PMID">11742414</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">414</biblScope>
			<biblScope unit="issue">6865</biblScope>
			<biblScope unit="page" from="813" to="820" />
			<date type="published" when="2001-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">M</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">I</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haw</forename><surname>Neil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">E</forename><surname>Manley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Cull</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hadden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Holman</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.321.7258.405</idno>
		<idno type="PMID">10938048</idno>
		<idno type="PMCID">PMC27454</idno>
		<idno type="ark">ark:/67375/NVC-V0T1TV2L-N</idno>
		<idno type="istexId">02D51CA22C9FAE878DF42FBD87119E65FCEC0C56</idno>
		<ptr type="open-access" target="https://www.bmj.com/content/321/7258/405.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<idno type="ISSN">0959-8138</idno>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="issue">7258</biblScope>
			<biblScope unit="page" from="405" to="412" />
			<date type="published" when="2000-08-12" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xueliang</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Matsumura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diane</forename><surname>Edelstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luciano</forename><surname>Rossetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zsuzsanna</forename><surname>Zsengellér</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Csaba</forename><surname>Szabó</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Brownlee</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci18127</idno>
		<idno type="PMID">14523042</idno>
		<idno type="PMCID">PMC198524</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/18127/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1049" to="1057" />
			<date type="published" when="2003-10-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Interactions Between Hyperglycemia and Hypoxia: Implications for Diabetic Retinopathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Nyengaard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Kilo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Williamson</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.53.11.2931</idno>
		<idno type="PMID">15504974</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/53/11/2931.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2931" to="2938" />
			<date type="published" when="2004-10-25" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Babaei-Jadidi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Karachalias</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Battah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.52.8.2110</idno>
		<idno type="PMID">12882930</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/52/8/2110.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2110" to="2120" />
			<date type="published" when="2003-07-25" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Nishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diane</forename><surname>Edelstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xue</forename><forename type="middle">Liang</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sho-Ichi</forename><surname>Yamagishi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Matsumura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasufumi</forename><surname>Kaneda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Yorek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Beebe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Oates</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans-Peter</forename><surname>Hammes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ida</forename><surname>Giardino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Brownlee</surname></persName>
		</author>
		<idno type="DOI">10.1038/35008121</idno>
		<idno type="PMID">10783895</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">404</biblScope>
			<biblScope unit="issue">6779</biblScope>
			<biblScope unit="page" from="787" to="790" />
			<date type="published" when="2000-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X-L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Edelstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Rossetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">G</forename><surname>Fantus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Ziyadeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Brownlee</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.97.22.12222</idno>
		<idno type="PMID">11050244</idno>
		<idno type="PMCID">PMC17322</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/97/22/12222.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="12222" to="12226" />
			<date type="published" when="2000-10-24" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Increased Dicarbonyl Metabolism in Endothelial Cells in Hyperglycemia Induces Anoikis and Impairs Angiogenesis by RGD and GFOGER Motif Modification</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Dobler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">E</forename><surname>Eboigbodin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
		</author>
		<idno type="DOI">10.2337/db05-1634</idno>
		<idno type="PMID">16804064</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/55/7/1961.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1961" to="1969" />
			<date type="published" when="2006-06-27" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans-Peter</forename><surname>Hammes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xueliang</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diane</forename><surname>Edelstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Taguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Matsumura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qida</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jihong</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angelika</forename><surname>Bierhaus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Nawroth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dieter</forename><surname>Hannak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Neumaier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Regine</forename><surname>Bergfeld</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ida</forename><surname>Giardino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Brownlee</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm834</idno>
		<idno type="PMID">12592403</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<title level="j" type="abbrev">Nat Med</title>
		<idno type="ISSN">1078-8956</idno>
		<idno type="ISSNe">1546-170X</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="294" to="299" />
			<date type="published" when="2003-02-18" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elena</forename><surname>Berrone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elena</forename><surname>Beltramo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carmela</forename><surname>Solimine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alessandro</forename><forename type="middle">Ubertalli</forename><surname>Ape</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Massimo</forename><surname>Porta</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m600418200</idno>
		<idno type="PMID">16452468</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/281/14/9307.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="9307" to="9313" />
			<date type="published" when="2006-02-01" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayuki</forename><surname>Yamamoto</surname></persName>
		</author>
		<idno type="DOI">10.1089/ars.2005.7.385</idno>
		<idno type="PMID">15706085</idno>
	</analytic>
	<monogr>
		<title level="j">Antioxidants &amp; Redox Signaling</title>
		<title level="j" type="abbrev">Antioxidants &amp; Redox Signaling</title>
		<idno type="ISSN">1523-0864</idno>
		<idno type="ISSNe">1557-7716</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="385" to="394" />
			<date type="published" when="2005-03" />
			<publisher>Mary Ann Liebert Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Antioxidant and cytoprotective responses to redox stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanne</forename><surname>Mathers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">A</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Mcmahon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">D C</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">D</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lesley</forename><forename type="middle">I</forename><surname>Mclellan</surname></persName>
		</author>
		<idno type="DOI">10.1042/bss0710157</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/ebfc/54f8e569c7a53f26ed04f6cb56a83d2fda7d.pdf" />
	</analytic>
	<monogr>
		<title level="j">Biochemical Society Symposium</title>
		<title level="j" type="abbrev">Biochem. Soc. Symp.</title>
		<idno type="ISSN">0067-8694</idno>
		<idno type="ISSNe">1744-1439</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="157" to="176" />
			<date type="published" when="2004-03" />
			<publisher>Portland Press Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Enhanced Expression of the Transcription Factor Nrf2 by Cancer Chemopreventive Agents: Role of Antioxidant Response Element-Like Sequences in the nrf2 Promoter</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-K</forename><surname>Kwak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">W</forename><surname>Kensler</surname></persName>
		</author>
		<idno type="DOI">10.1128/mcb.22.9.2883-2892.2002</idno>
		<idno type="PMID">11940647</idno>
		<idno type="PMCID">PMC133753</idno>
		<ptr type="open-access" target="https://mcb.asm.org/content/22/9/2883.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<title level="j" type="abbrev">Molecular and Cellular Biology</title>
		<idno type="ISSN">0270-7306</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2883" to="2892" />
			<date type="published" when="2002-05-01" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide array</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">K</forename><surname>Thimmulappa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Mai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Srisuma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">W</forename><surname>Kensler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Biswal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="5196" to="5203" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-I</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Okawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ohtsuji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zenke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Chiba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Igarashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<idno type="DOI">10.1128/mcb.24.16.7130-7139.2004</idno>
		<idno type="PMID">15282312</idno>
		<idno type="PMCID">PMC479737</idno>
		<ptr type="open-access" target="https://mcb.asm.org/content/24/16/7130.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<title level="j" type="abbrev">Molecular and Cellular Biology</title>
		<idno type="ISSN">0270-7306</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="7130" to="7139" />
			<date type="published" when="2004-07-28" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The world according to Maf</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Motohashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Shavit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Igarashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Engel</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/25.15.2953</idno>
		<idno type="PMID">9224592</idno>
		<idno type="PMCID">PMC146842</idno>
		<idno type="ark">ark:/67375/HXZ-1H0W1T75-C</idno>
		<idno type="istexId">77B2BEC44DA63E1297B20933E233B78EDFA4C174</idno>
		<ptr type="open-access" target="https://academic.oup.com/nar/article-pdf/25/15/2953/9467685/25-15-2953.pdf" />
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<idno type="ISSNe">1362-4962</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2953" to="2959" />
			<date type="published" when="1997-08-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donna</forename><forename type="middle">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shih-Ching</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zheng</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geetha</forename><forename type="middle">M</forename><surname>Habib</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">W</forename><surname>Lieberman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Hannink</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m501279200</idno>
		<idno type="PMID">15983046</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/280/34/30091.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="issue">34</biblScope>
			<biblScope unit="page" from="30091" to="30099" />
			<date type="published" when="2005-06-27" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">T</forename><surname>Dinkova-Kostova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">D</forename><surname>Holtzclaw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">N</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Katoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Talalay</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.172398899</idno>
		<idno type="PMID">12193649</idno>
		<idno type="PMCID">PMC129367</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/99/18/11908.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="11908" to="11913" />
			<date type="published" when="2002-08-22" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">An Auto-regulatory Loop between Stress Sensors INrf2 and Nrf2 Controls Their Cellular Abundance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ok-Hee</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abhinav</forename><forename type="middle">K</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><surname>Papusha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anil</forename><forename type="middle">K</forename><surname>Jaiswal</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m706517200</idno>
		<idno type="PMID">17925401</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/282/50/36412.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="issue">50</biblScope>
			<biblScope unit="page" from="36412" to="36420" />
			<date type="published" when="2007-10-09" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Nuclear import and export signals in control of Nrf2.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abhinav</forename><forename type="middle">K</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Bloom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anil</forename><forename type="middle">K</forename><surname>Jaiswal</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.a117.502083</idno>
		<idno type="PMID">28159765</idno>
		<idno type="PMCID">PMC5290979</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/292/5/2052.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2052" to="2052" />
			<date type="published" when="2017-02-03" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Molecular mechanism of human Nrf2 activation and degradation: Role of sequential phosphorylation by protein kinase CK2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jingbo</forename><surname>Pi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yushi</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">M</forename><surname>Reece</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jason</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dianxin</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">L</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">E</forename><surname>Fahl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Shugar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jie</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Qu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.freeradbiomed.2007.03.001</idno>
		<idno type="PMID">17512459</idno>
		<idno type="PMCID">PMC1950666</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1950666?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Free Radical Biology and Medicine</title>
		<title level="j" type="abbrev">Free Radical Biology and Medicine</title>
		<idno type="ISSN">0891-5849</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1797" to="1806" />
			<date type="published" when="2007-06-15" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">GSK-3β Acts Upstream of Fyn Kinase in Regulation of Nuclear Export and Degradation of NF-E2 Related Factor 2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abhinav</forename><forename type="middle">K</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anil</forename><forename type="middle">K</forename><surname>Jaiswal</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m611336200</idno>
		<idno type="PMID">17403689</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/282/22/16502.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="16502" to="16510" />
			<date type="published" when="2007-04-02" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Laminar Flow Induction of Antioxidant Response Element-mediated Genes in Endothelial Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xi-Lin</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Signe</forename><forename type="middle">E</forename><surname>Varner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anjali</forename><forename type="middle">S</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janice</forename><forename type="middle">Y</forename><surname>Grey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suzanne</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">K</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">A</forename><surname>Wasserman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Russell</forename><forename type="middle">M</forename><surname>Medford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anil</forename><forename type="middle">K</forename><surname>Jaiswal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><surname>Kunsch</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m203161200</idno>
		<idno type="PMID">12370194</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/278/2/703.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="703" to="711" />
			<date type="published" when="2002-10-04" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Analysis of glucosinolates, isothiocyanates, and amine degradation products in vegetable extracts and blood plasma by LC–MS/MS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lijiang</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">J</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nigel</forename><forename type="middle">P</forename><surname>Botting</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ab.2005.09.040</idno>
		<idno type="PMID">16289008</idno>
	</analytic>
	<monogr>
		<title level="j">Analytical Biochemistry</title>
		<title level="j" type="abbrev">Analytical Biochemistry</title>
		<idno type="ISSN">0003-2697</idno>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="234" to="243" />
			<date type="published" when="2005-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edwin</forename><forename type="middle">W</forename><surname>Ades</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francisco</forename><forename type="middle">J</forename><surname>Candal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Swerlick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Velma</forename><forename type="middle">G</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan.</forename><surname>Summers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Diane</forename><forename type="middle">C</forename><surname>Bosse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">J</forename><surname>Lawley</surname></persName>
		</author>
		<idno type="DOI">10.1111/1523-1747.ep12613748</idno>
		<idno type="PMID">1361507</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Investigative Dermatology</title>
		<title level="j" type="abbrev">Journal of Investigative Dermatology</title>
		<idno type="ISSN">0022-202X</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="683" to="690" />
			<date type="published" when="1992-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Monoclonal antibodies identify a group of nuclear pore complex glycoproteins</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Snow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Senior</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Gerace</surname></persName>
		</author>
		<idno type="DOI">10.1083/jcb.104.5.1143</idno>
		<idno type="PMID">2437126</idno>
		<idno type="PMCID">PMC2114474</idno>
		<ptr type="open-access" target="http://jcb.rupress.org/content/104/5/1143.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Cell Biology</title>
		<title level="j" type="abbrev">The Journal of Cell Biology</title>
		<idno type="ISSN">0021-9525</idno>
		<idno type="ISSNe">1540-8140</idno>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1143" to="1156" />
			<date type="published" when="1987-05-01" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ke</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0006-2952(00)00319-1</idno>
		<idno type="PMID">10825467</idno>
		<idno type="PII">S0006-2952(00)00319-1</idno>
		<idno type="ark">ark:/67375/6H6-BWF3RD65-7</idno>
		<idno type="istexId">2C4D1D272214D5560AB68F5C18D7299BD969C8B1</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical Pharmacology</title>
		<title level="j" type="abbrev">Biochemical Pharmacology</title>
		<idno type="ISSN">0006-2952</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="221" to="231" />
			<date type="published" when="2000-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xi-Lin</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geraldine</forename><surname>Dodd</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suzanne</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaolan</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">A</forename><surname>Wasserman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brad</forename><forename type="middle">H</forename><surname>Rovin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><surname>Kunsch</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpheart.00651.2005</idno>
		<idno type="PMID">16339837</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/96f7/c95d1cde0daa7fe5ac42c8be51a087a67339.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology-Heart and Circulatory Physiology</title>
		<title level="j" type="abbrev">American Journal of Physiology-Heart and Circulatory Physiology</title>
		<idno type="ISSN">0363-6135</idno>
		<idno type="ISSNe">1522-1539</idno>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="H1862" to="H1870" />
			<date type="published" when="2006-05" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Vitamin B12 (cobalamin) deficiency in elderly patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Andres</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">H</forename><surname>Loukili</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Noel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Kaltenbach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">B</forename><surname>Abdelgheni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">E</forename><surname>Perrin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Noblet-Dick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Maloisel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Schlienger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Blickle</surname></persName>
		</author>
		<idno type="DOI">10.1503/cmaj.1031155</idno>
		<idno type="PMID">15289425</idno>
		<idno type="PMCID">PMC490077</idno>
		<ptr type="open-access" target="http://www.cmaj.ca/content/171/3/251.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association Journal</title>
		<title level="j" type="abbrev">Canadian Medical Association Journal</title>
		<idno type="ISSN">0820-3946</idno>
		<idno type="ISSNe">1488-2329</idno>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="251" to="259" />
			<date type="published" when="2004-08-03" />
			<publisher>Joule Inc.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Role of Nrf2 in the Regulation of CD36 and Stress Protein Expression in Murine Macrophages</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuro</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ken</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emilio</forename><surname>Ruiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">S</forename><surname>Leake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroyuki</forename><surname>Unoki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayuki</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><forename type="middle">E</forename><surname>Mann</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.res.0000119171.44657.45</idno>
		<idno type="PMID">14752028</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.RES.0000119171.44657.45" />
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<title level="j" type="abbrev">Circulation Research</title>
		<idno type="ISSN">0009-7330</idno>
		<idno type="ISSNe">1524-4571</idno>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="609" to="616" />
			<date type="published" when="2004-03-19" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sophie</forename><surname>Tamareille</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olivier</forename><surname>Mignen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thierry</forename><surname>Capiod</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catherine</forename><surname>Rücker-Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Danielle</forename><surname>Feuvray</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ceca.2005.09.008</idno>
		<idno type="PMID">16243395</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Calcium</title>
		<title level="j" type="abbrev">Cell Calcium</title>
		<idno type="ISSN">0143-4160</idno>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="47" to="55" />
			<date type="published" when="2006-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Gene Expression Profile of Aging and Its Retardation by Caloric Restriction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C-K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Klopp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Weindruch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Prolla</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.285.5432.1390</idno>
		<idno type="PMID">10464095</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/1a63/d9f8c79e6ba02366e88fe0393158b65c6128.pdf" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">5432</biblScope>
			<biblScope unit="page" from="1390" to="1393" />
			<date type="published" when="1999-08-27" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jong-Min</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcus</forename><forename type="middle">J</forename><surname>Calkins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaimin</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuet</forename><forename type="middle">Wai</forename><surname>Kan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m211558200</idno>
		<idno type="PMID">12556532</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/278/14/12029.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="12029" to="12038" />
			<date type="published" when="2003-01-28" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mi-Kyoung</forename><surname>Kwak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobunao</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ken</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hozumi</forename><surname>Motohashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayuki</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">W</forename><surname>Kensler</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m211898200</idno>
		<idno type="PMID">12506115</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/278/10/8135.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="8135" to="8145" />
			<date type="published" when="2002-12-27" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Involvement of GSH metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="165" to="177" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bertl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Gerhauser</surname></persName>
		</author>
		<idno type="DOI">10.1158/1535-7163.mct-05-0324</idno>
		<idno type="PMID">16546971</idno>
		<ptr type="open-access" target="http://mct.aacrjournals.org/content/molcanther/5/3/575.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer Therapeutics</title>
		<title level="j" type="abbrev">Molecular Cancer Therapeutics</title>
		<idno type="ISSN">1535-7163</idno>
		<idno type="ISSNe">1538-8514</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="575" to="585" />
			<date type="published" when="2006-03-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Thornalley</surname></persName>
		</author>
		<idno type="DOI">10.1054/bjoc.2000.1636</idno>
		<idno type="PMID">11237388</idno>
		<idno type="PMCID">PMC2363795</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/6691636.pdf" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<title level="j" type="abbrev">Br J Cancer</title>
		<idno type="ISSNe">1532-1827</idno>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="670" to="673" />
			<date type="published" when="2001" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Mechanism of Action of Sulforaphane: Inhibition of p38 Mitogen-Activated Protein Kinase Isoforms Contributing to the Induction of Antioxidant Response Element–Mediated Heme Oxygenase-1 in Human Hepatoma HepG2 Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Sam</forename><surname>Keum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Siwang</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter Pil-Jae</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoling</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Hwan</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Changjiang</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiahuai</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anupam</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ah-Ng Tony</forename><surname>Kong</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-05-3513</idno>
		<idno type="PMID">16951197</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/66/17/8804.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Res</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="8804" to="8813" />
			<date type="published" when="2006-09-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janet</forename><forename type="middle">V</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">W</forename><surname>Foss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joshua</forename><forename type="middle">M</forename><surname>Rady</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timothy</forename><forename type="middle">L</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">J</forename><surname>Templeton</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2407-7-183</idno>
		<idno type="PMID">17894894</idno>
		<idno type="PMCID">PMC2071920</idno>
		<ptr type="open-access" target="https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-7-183" />
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<title level="j" type="abbrev">BMC Cancer</title>
		<idno type="ISSNe">1471-2407</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">183</biblScope>
			<date type="published" when="2007-09-25" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Phenylethyl Isothiocyanate Induces Apoptotic Signaling via Suppressing Phosphatase Activity against c-Jun N-terminal Kinase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi-Rong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rajashree</forename><surname>Kori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ant</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tse-Hua</forename><surname>Tan</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m202070200</idno>
		<idno type="PMID">12171915</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/277/42/39334.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="issue">42</biblScope>
			<biblScope unit="page" from="39334" to="39342" />
			<date type="published" when="2002-08-08" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi-Tai</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gow-Chin</forename><surname>Yen</surname></persName>
		</author>
		<idno type="DOI">10.1093/carcin/bgi185</idno>
		<idno type="PMID">16033772</idno>
		<idno type="ark">ark:/67375/HXZ-T7V00S7L-N</idno>
		<idno type="istexId">D305AA6232B28B296A109A4966B70ED6C4B23F46</idno>
		<ptr type="open-access" target="https://academic.oup.com/carcin/article-pdf/26/12/2138/7088374/bgi185.pdf" />
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<idno type="ISSN">0143-3334</idno>
		<idno type="ISSNe">1460-2180</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2138" to="2148" />
			<date type="published" when="2005-07-20" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Mitochondrial reactive oxygen species-mediated signaling in endothelial cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">D</forename><surname>Gutterman</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpheart.01283.2006</idno>
		<idno type="PMID">17237240</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/09a5/14fd889d63c9faf3a382350f4d78570e09cd.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology-Heart and Circulatory Physiology</title>
		<title level="j" type="abbrev">American Journal of Physiology-Heart and Circulatory Physiology</title>
		<idno type="ISSN">0363-6135</idno>
		<idno type="ISSNe">1522-1539</idno>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="H2023" to="H2031" />
			<date type="published" when="2007-05" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Primary role of superoxide anion generation in the cascade of events leading to endothelial dysfunction and damage in high glucose treated HUVEC</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisa</forename><surname>Quagliaro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ludovica</forename><surname>Piconi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberta</forename><surname>Assaloni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Da Ros</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Csaba</forename><surname>Szabó</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonio</forename><surname>Ceriello</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.numecd.2006.01.007</idno>
		<idno type="PMID">16891102</idno>
	</analytic>
	<monogr>
		<title level="j">Nutrition, Metabolism and Cardiovascular Diseases</title>
		<title level="j" type="abbrev">Nutrition, Metabolism and Cardiovascular Diseases</title>
		<idno type="ISSN">0939-4753</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="257" to="267" />
			<date type="published" when="2007-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Hink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Mollnau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Oelze</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Matheis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Skatchkov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Thaiss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rak</forename><forename type="middle">A K</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Warnholtz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Meinertz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Griendling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Forstermann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Munzel</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.res.88.2.e14</idno>
		<idno type="PMID">11157681</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.RES.88.2.e14" />
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<title level="j" type="abbrev">Circulation Research</title>
		<idno type="ISSN">0009-7330</idno>
		<idno type="ISSNe">1524-4571</idno>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="e14" to="e22" />
			<date type="published" when="2001-02-02" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Guzik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mussa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Gastaldi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sadowski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ratnatunga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Pillai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Channon</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.0000012748.58444.08</idno>
		<idno type="PMID">11940543</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000012748.58444.08" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1656" to="1662" />
			<date type="published" when="2002-03-18" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Anoikis mechanisms</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><forename type="middle">M</forename><surname>Frisch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Screaton</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0955-0674(00)00251-9</idno>
		<idno type="PMID">11544023</idno>
		<idno type="PII">S0955-0674(00)00251-9</idno>
		<idno type="ark">ark:/67375/6H6-P3FPD876-4</idno>
		<idno type="istexId">EEF845CDCA0C3953BD6D36CDABFE09C0BCDD2AC1</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Cell Biology</title>
		<title level="j" type="abbrev">Current Opinion in Cell Biology</title>
		<idno type="ISSN">0955-0674</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="555" to="562" />
			<date type="published" when="2001-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Xanthine Oxidase Is Involved in Free Radical Production in Type 1 Diabetes: Protection by Allopurinol</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-C</forename><surname>Desco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Asensi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Marquez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Martinez-Valls</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Vento</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">V</forename><surname>Pallardo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sastre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vina</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.51.4.1118</idno>
		<idno type="PMID">11916934</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/51/4/1118.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1118" to="1124" />
			<date type="published" when="2002-04-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Substrate-Induced Up-Regulation of Aldose Reductase by Methylglyoxal, a Reactive Oxoaldehyde Elevated in Diabetes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Paek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Yabe-Nishimura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">G</forename><surname>Seo</surname></persName>
		</author>
		<idno type="DOI">10.1124/mol.61.5.1184</idno>
		<idno type="PMID">11961137</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Pharmacology</title>
		<idno type="ISSN">0026-895X</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1184" to="1191" />
			<date type="published" when="2002-05-01" />
			<publisher>American Society for Pharmacology &amp; Experimental Therapeutics (ASPET)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Esther</forename><surname>Lopez-Garcia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><forename type="middle">B</forename><surname>Schulze</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Teresa</forename><forename type="middle">T</forename><surname>Fung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">B</forename><surname>Meigs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nader</forename><surname>Rifai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joann</forename><forename type="middle">E</forename><surname>Manson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">B</forename><surname>Hu</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/80.4.1029</idno>
		<idno type="PMID">15447916</idno>
		<ptr type="open-access" target="https://academic.oup.com/ajcn/article-pdf/80/4/1029/23714894/1029.pdf" />
	</analytic>
	<monogr>
		<title level="j">The American Journal of Clinical Nutrition</title>
		<idno type="ISSN">0002-9165</idno>
		<idno type="ISSNe">1938-3207</idno>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1029" to="1035" />
			<date type="published" when="2004-10-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. A randomized trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Esposito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Marfella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ciotola</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.accreview.2004.11.073</idno>
	</analytic>
	<monogr>
		<title level="j">ACC Current Journal Review</title>
		<title level="j" type="abbrev">ACC Current Journal Review</title>
		<idno type="ISSN">1062-1458</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="16" to="17" />
			<date type="published" when="2004-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Noveln-3 Fatty Acid Oxidation Products Activate Nrf2 by Destabilizing the Association between Keap1 and Cullin3</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ling</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiakun</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Konjeti</forename><forename type="middle">R</forename><surname>Sekhar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huiyong</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">F</forename><surname>Yared</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><forename type="middle">N</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soumya</forename><surname>Sasi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timothy</forename><forename type="middle">P</forename><surname>Dalton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">E</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jefferson</forename><forename type="middle">Y</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jason</forename><forename type="middle">D</forename><surname>Morrow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">L</forename><surname>Freeman</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m607622200</idno>
		<idno type="PMID">17127771</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/282/4/2529.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2529" to="2537" />
			<date type="published" when="2006-11-25" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Aleksunes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Yeager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Gyamfi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Esterly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">L</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">D</forename><surname>Klaassen</surname></persName>
		</author>
		<idno type="DOI">10.1124/jpet.107.135822</idno>
		<idno type="PMID">18281592</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacology and Experimental Therapeutics</title>
		<title level="j" type="abbrev">Journal of Pharmacology and Experimental Therapeutics</title>
		<idno type="ISSN">0022-3565</idno>
		<idno type="ISSNe">1521-0103</idno>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="655" to="664" />
			<date type="published" when="2008-02-05" />
			<publisher>American Society for Pharmacology &amp; Experimental Therapeutics (ASPET)</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
